Institutional Ownership Corvus Pharmaceuticals, Inc. (CRVS)
This table provides information about the institutional ownership of Corvus Pharmaceuticals, Inc. (CRVS). We have compiled data on the 100 institutions that hold shares in the stock, with a total of 38.9 Million shares, which have been reported (via 13F filing form) to have a value of $236 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
7,165,006
shares
|
$43.6 Million
1.02% of portfolio
|
Q2 2025
Added 3.19%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Aug 14, 2025 Q2 2025 |
7,042,373
shares
|
$42.8 Million
0.06% of portfolio
|
Q2 2025
Added 152.63%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
3,280,709
shares
|
$19.9 Million
0.0% of portfolio
|
Q2 2025
Added 31.54%
|
|
|
Adams Street Partners LLC
Chicago, IL |
Aug 13, 2025 Q2 2025 |
3,275,616
shares
|
$19.9 Million
9.69% of portfolio
|
Q1 2018
Added 7.01%
|
|
|
Rtw Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
2,679,479
shares
|
$16.3 Million
0.16% of portfolio
|
Q4 2024
New holding
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Aug 13, 2025 Q2 2025 |
2,234,566
shares
|
$13.6 Million
1.89% of portfolio
|
Q4 2024
Added 49.24%
|
|
|
Foresite Capital Management Vi LLC
Larkspur, CA |
Aug 12, 2025 Q2 2025 |
1,731,233
shares
|
$10.5 Million
3.89% of portfolio
|
Q2 2025
Added 9.49%
|
|
|
Perceptive Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
1,438,595
shares
|
$8.75 Million
0.25% of portfolio
|
Q2 2025
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,361,740
shares
|
$8.28 Million
0.0% of portfolio
|
Q2 2025
Added 130.69%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
894,405
shares
|
$5.44 Million
0.0% of portfolio
|
Q2 2025
Added 32.79%
|
|
|
Dcf Advisers, LLC
Greenwich, CT |
Aug 12, 2025 Q2 2025 |
757,500
shares
|
$4.61 Million
1.51% of portfolio
|
Q2 2025
Added 89.38%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
664,768
shares
|
$4.04 Million
0.0% of portfolio
|
Q2 2025
Added 188.98%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
562,024
shares
|
$3.42 Million
0.0% of portfolio
|
Q2 2024
Added 7.47%
|
|
|
Ghost Tree Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
500,000
shares
|
$3.04 Million
0.99% of portfolio
|
Q3 2024
New holding
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
403,149
shares
|
$2.45 Million
0.0% of portfolio
|
Q2 2025
Added 268.86%
|
|
|
Telemetry Investments, L.L.C.
New York, NY |
Feb 14, 2023 Q4 2022 |
390,000
shares
|
$2.37 Million
0.52% of portfolio
|
Q4 2022
Reduced 25.29%
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
343,526
shares
|
$2.09 Million
0.0% of portfolio
|
Q2 2025
Added 312.74%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Jul 22, 2025 Q2 2025 |
318,732
shares
|
$1.94 Million
0.09% of portfolio
|
Q2 2025
New holding
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
223,913
shares
|
$1.36 Million
0.0% of portfolio
|
Q2 2025
Reduced 27.38%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
212,700
shares
|
$1.29 Million
0.0% of portfolio
|
Q2 2025
Reduced 10.03%
|
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
201,651
shares
|
$1.23 Million
0.0% of portfolio
|
Q2 2025
Added 30.29%
|
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Aug 14, 2025 Q2 2025 |
183,094
shares
|
$1.11 Million
0.2% of portfolio
|
Q2 2025
Reduced 11.06%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
170,211
shares
|
$1.03 Million
0.0% of portfolio
|
Q2 2025
Reduced 53.79%
|
|
|
Towerview LLC
|
Aug 06, 2025 Q2 2025 |
170,000
shares
|
$1.03 Million
0.51% of portfolio
|
Q2 2025
Added 33.33%
|
|
|
Empirical Financial Services, LLC D.B.A. Empirical Wealth Management
|
Jul 21, 2025 Q2 2025 |
168,000
shares
|
$1.02 Million
0.02% of portfolio
|
Q2 2025
New holding
|